GeneDx Holdings Corp.
WGS
$56.33
$4.538.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -869.77% | -424.86% | 8.14% | 137.05% | 67.74% |
| Total Depreciation and Amortization | 19.92% | 28.40% | 9.19% | 18.65% | 8.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 515.22% | 251.01% | 429.10% | -57.56% | 22.70% |
| Change in Net Operating Assets | -791.20% | 103.38% | 50.10% | -360.64% | 143.62% |
| Cash from Operations | -418.29% | 2.92% | 458.75% | 331.30% | 162.04% |
| Capital Expenditure | -5.29% | -42.52% | -855.42% | -75.22% | -1,283.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -229.43% | -379.10% | 120.89% | 96.32% | -354.98% |
| Cash from Investing | -83.41% | -2,033.33% | 39.56% | -60.13% | -1,216.01% |
| Total Debt Issued | 598.13% | -- | -- | -- | -- |
| Total Debt Repaid | -6,370.03% | 55.37% | -71.99% | -61.55% | -97.19% |
| Issuance of Common Stock | -27.35% | -26.65% | -18.34% | 775.18% | 2,962.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 181.31% | -25.24% | -22.91% | 188.49% | 3,231.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -176.41% | -66.94% | 1,101.76% | 7.29% | 190.53% |